| Trial ID: | L6901 |
| Source ID: | NCT01052597
|
| Associated Drug: |
Curcumin
|
| Title: |
Curcumin for Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Cardiovascular Abnormalities
|
| Interventions: |
DRUG: curcumin
|
| Outcome Measures: |
Primary: to determine the effectiveness of curcumin on reduction of atherosclerotic events and risks in Type 2 diabetic patients, 12 months | Secondary: To examine the effectiveness of curcumin on the reduction of blood sugar, glycosylated hemoglobin (HBA1c), lipid profile, and insulin resistance, 12 months
|
| Sponsor/Collaborators: |
Sponsor: Srinakharinwirot University | Collaborators: Ministry of Health, Thailand
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-07
|
| Completion Date: |
2010-03
|
| Results First Posted: |
|
| Last Update Posted: |
2010-01-20
|
| Locations: |
HRH Princess Maha Chakri Sirindhorn Medical Center, Ongkarak, Nakornnayok, 26120, Thailand
|
| URL: |
https://clinicaltrials.gov/show/NCT01052597
|
